BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, Leibovich BC, Parker AS. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma. BJU Int 2012;110:956-60. [PMID: 22300498 DOI: 10.1111/j.1464-410X.2012.10937.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Hwang KT, Han W, Lee SM, Choi J, Kim J, Rhu J, Kim YA, Noh DY. Prognostic influence of 3-dimensional tumor volume on breast cancer compared to conventional 1-dimensional tumor size. Ann Surg Treat Res 2018;95:183-91. [PMID: 30310801 DOI: 10.4174/astr.2018.95.4.183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Song W, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma. World J Urol 2016;34:83-8. [PMID: 25981404 DOI: 10.1007/s00345-015-1592-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Gundara JS, Gill AJ, Samra JS. Efficacy of primary tumour volume as a predictor of survival compared with size alone in pancreatic ductal adenocarcinoma. Oncol Lett 2015;10:744-8. [PMID: 26622563 DOI: 10.3892/ol.2015.3254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Planz VB, Lubner MG, Pickhardt PJ. Volumetric analysis at abdominal CT: oncologic and non-oncologic applications. Br J Radiol 2019;92:20180631. [PMID: 30457881 DOI: 10.1259/bjr.20180631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Chen SH, Xu LY, Wu YP, Ke ZB, Huang P, Lin F, Li XD, Xue XY, Wei Y, Zheng QS, Xu N. Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma. BMC Cancer 2021;21:79. [PMID: 33468079 DOI: 10.1186/s12885-021-07795-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Choi SM, Choi DK, Kim TH, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG. A comparison of radiologic tumor volume and pathologic tumor volume in renal cell carcinoma (RCC). PLoS One 2015;10:e0122019. [PMID: 25799553 DOI: 10.1371/journal.pone.0122019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
7 Chen MY, Woodruff MA, Kua B, Rukin NJ. Rapid Segmentation of Renal Tumours to Calculate Volume Using 3D Interpolation. J Digit Imaging 2021;34:351-6. [PMID: 33564999 DOI: 10.1007/s10278-020-00416-z] [Reference Citation Analysis]
8 Shoji S, Nakano M, Sato H, Tang XY, Osamura YR, Terachi T, Uchida T, Takeya K. The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma. Clin Exp Metastasis 2014;31:111-34. [PMID: 23959576 DOI: 10.1007/s10585-013-9612-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
9 Zhou L, Guo J, Wang H, Wang G. The Zhongshan score: a novel and simple anatomic classification system to predict perioperative outcomes of nephron-sparing surgery. Medicine (Baltimore) 2015;94:e506. [PMID: 25654399 DOI: 10.1097/MD.0000000000000506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Bajalia EM, Parikh KA, Haehn DA, Kahn AE, Ball CT, Thiel DD. Assessment of Advanced Perioperative Outcomes to Identify the True Learning Curve of Robotic-assisted Partial Nephrectomy. Urology 2020;144:136-41. [PMID: 32619599 DOI: 10.1016/j.urology.2020.06.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]